194 related articles for article (PubMed ID: 28527077)
1. Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment.
Grazzi L
Neurol Sci; 2017 May; 38(Suppl 1):141-143. PubMed ID: 28527077
[TBL] [Abstract][Full Text] [Related]
2. Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm.
Liberini P; Pari E; Gazzina S; Caratozzolo S; Rao R; Padovani A
Neurol Sci; 2014 May; 35 Suppl 1():41-3. PubMed ID: 24867834
[TBL] [Abstract][Full Text] [Related]
3. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A: a new option for treatment of chronic migraine with medication overuse.
Grazzi L; Usai S
Neurol Sci; 2014 May; 35 Suppl 1():37-9. PubMed ID: 24867833
[TBL] [Abstract][Full Text] [Related]
5. [Method of onabotulinumtoxin type A injection in chronic migraine: the PREEMPT protocol in clinical practice].
Latysheva NV; Naprienko MV; Filatova EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):93-96. PubMed ID: 34481443
[TBL] [Abstract][Full Text] [Related]
6. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
Santoro A; Fontana A; Miscio AM; Zarrelli MM; Copetti M; Leone MA
Neurol Sci; 2017 Oct; 38(10):1779-1789. PubMed ID: 28726049
[TBL] [Abstract][Full Text] [Related]
7. Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year.
Aicua-Rapun I; Martínez-Velasco E; Rojo A; Hernando A; Ruiz M; Carreres A; Porqueres E; Herrero S; Iglesias F; Guerrero AL
J Headache Pain; 2016 Dec; 17(1):112. PubMed ID: 27957623
[TBL] [Abstract][Full Text] [Related]
8. Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers.
Tassorelli C; Aguggia M; De Tommaso M; Geppetti P; Grazzi L; Pini LA; Sarchielli P; Tedeschi G; Martelletti P; Cortelli P
J Headache Pain; 2017 Dec; 18(1):66. PubMed ID: 28667550
[TBL] [Abstract][Full Text] [Related]
9. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
10. Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience.
Grazzi L; Usai S
Neurol Sci; 2015 May; 36 Suppl 1():33-5. PubMed ID: 26017508
[TBL] [Abstract][Full Text] [Related]
11. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
Cernuda-Morollón E; Ramón C; Larrosa D; Alvarez R; Riesco N; Pascual J
Cephalalgia; 2015 Sep; 35(10):864-8. PubMed ID: 25431141
[TBL] [Abstract][Full Text] [Related]
12. Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
Vernieri F; Paolucci M; Altamura C; Pasqualetti P; Mastrangelo V; Pierangeli G; Cevoli S; D'Amico D; Grazzi L
Headache; 2019 Sep; 59(8):1300-1309. PubMed ID: 31454075
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic migraine with intramuscular pericranial injections of onabotulinumtoxin a.
Belvis R; Mas N
Recent Pat CNS Drug Discov; 2014; 9(3):181-92. PubMed ID: 25643127
[TBL] [Abstract][Full Text] [Related]
14. The use of onabotulinum toxin A (Botox(®)) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study.
Russo M; Manzoni GC; Taga A; Genovese A; Veronesi L; Pasquarella C; Sansebastiano GE; Torelli P
Neurol Sci; 2016 Jul; 37(7):1127-31. PubMed ID: 27048312
[TBL] [Abstract][Full Text] [Related]
15. An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs "customized" dosing/injection paradigm.
Green MW; Rothrock JF
Toxicon; 2018 Jun; 147():116-119. PubMed ID: 29596847
[TBL] [Abstract][Full Text] [Related]
16. Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.
Vikelis M; Argyriou AA; Dermitzakis EV; Spingos KC; Makris N; Kararizou E
J Headache Pain; 2018 Sep; 19(1):87. PubMed ID: 30225735
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin A in chronic refractory migraine: premarketing experience].
Álvaro-González LC; Fernández-García JM; Aranzábal-Alustiza I; Castillo-Calvo B; Iriondo-Etxenagusia I; Rodríguez-Antigüedad A
Rev Neurol; 2012 Oct; 55(7):385-91. PubMed ID: 23011856
[TBL] [Abstract][Full Text] [Related]
18. Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results and changes in catastrophising attitude. Preliminary data.
Grazzi L; Grignani E; Sansone E; Raggi A; Leonardi M; D'Amico D
Neurol Sci; 2018 Jun; 39(Suppl 1):173-174. PubMed ID: 29904878
[No Abstract] [Full Text] [Related]
19. Catastrophizing attitude changes after onabotulinumtoxin A treatment in chronic migraine.
Grazzi L; Grignani E; Sansone E; Raggi A; D'Amico D; Andrasik F
Neurol Sci; 2019 May; 40(Suppl 1):201-202. PubMed ID: 30859415
[No Abstract] [Full Text] [Related]
20. Chronic migraine: current concepts and ongoing treatments.
Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
